Objective: This study evaluated the effect of fructose-1,6diphosphate (FDP), theophylline, or the addition of both together to the preservation solution (University of Wisconsin [UW]) on apoptosis during preservation and the effect of apoptosis minimization on the early reperfusion period after transplantation. Design: Prospective, randomized, and controlled animal study. Setting: Laboratory of a research institute. Subject: Male Wistar rats. Interventions: The jejunum was isolated and preserved for 6 hrs in UW solution. FDP and theophylline were added to the UW solution to evaluate their effects on apoptosis both alone and together. The role of adenosine with respect to FDP was examined by increasing endogenous adenosine. In addition, rats were subjected to intestinal transplantation for the evaluation of the effect of apoptosis on bacterial translocation, histology, and neutrophil infiltration after reperfusion. Measurements and Main Results: Caspase-3 activity, assayed both in vitro or by cleaved caspase-3 levels in Western blots or immunohistochemically, and the number of terminal deoxynucleotidyl transferase-mediated biotin-dUTP nick-end labeling (TUNEL)-positive cells decreased with FDP and with theophylline addition to UW solution. Increase of endogenous adenosine reversed the antiapoptotic effect of FDP. FDP and theophylline together demonstrated a more pronounced antiapoptotic effect and prevented bacterial translocation after transplantation. Conclusion: Supplementary FDP to UW solution decreased apoptosis through an adenosine-independent mechanism. Addition of theophylline to UW solution decreased both apoptosis and bacterial translocation. Concomitant theophylline and FDP addition to preservation solution is recommended to maintain low levels of apoptosis during intestinal hypothermic preservation and to decrease bacterial translocation. (Crit Care Med 2005; 33:827-834)
T he quality of organ preservation may have a dramatic impact on graft viability (1, 2) . Current cold storage solutions are unable to preserve intestinal grafts in optimal condition beyond 6 -10 hrs (3, 4) . So there is a need to develop better preservation solutions or techniques.
Two distinct modes of cell deathapoptosis and necrosis-are involved in the destruction of intestinal epithelial cells during ischemia/reperfusion (I/R), although the former plays a major role (5) . Postischemic organ failure may be affected by deregulation of the apoptotic process in intestinal transplantation. Ap-optosis affects the permeability of the intestinal mucosa, impairs its barrier function after transplantation, and leads to septic complications. This sepsis is caused in part by the small bowel's extreme susceptibility to I/R (6, 7) , which in turn induces bacterial translocation (BT) (8) . Moreover, the development of apoptosis during cold preservation is an important predictive factor of primary allograft dysfunction in humans (9) .
Fructose-1,6-diphosphate (FDP), a high glycolytic intermediate, improves heart (10) , liver (11) , and kidney (12) ischemic tissue preservation. FDP reduces the apoptotic index in rat intestinal transplantation: In a recent study, oral FDP administration 10 days before and after transplantation decreased apoptosis and increased mucosal cell proliferative index (13) . Among the mechanisms involved in the FDP antiapoptotic effect, prevention of adenosine triphosphate (ATP) depletion, chelating of extracellular calcium, and membrane-stabilizing action were proposed (13) .
The fact that FDP could affect pathways potentially involved in apoptosis modulation, and that ketohexoses exert a cytoprotective effect by inhibiting early cell death signals (14) , led us to hypothesize that FDP addition to preservation solutions could have an early antiapoptotic effect and could prevent apoptosis associated with cold preservation and, plausibly, postreperfusion injury.
Like FDP, adenosine is considered an inductor of functional improvement during I/R in several systems (15, 16) and has been described as antiapoptotic in various studies (17, 18) . Nevertheless, adenosine has also been described as proapoptotic in other research (19) . The fact that FDP induces endogenous accumulation of adenosine (15) , which has been previously described as protective, led us to hypothesize that the effect of FDP on apoptosis might be due to an increase in endogenous adenosine.
The present study assessed whether FDP is able to modulate apoptosis during preservation before intestinal transplantation and whether modifications of adenosine levels by FDP are involved in the modulation of apoptosis. Understanding the role of these factors might help to define the best conditions of tissue preservation before intestinal transplantation.
MATERIALS AND METHODS

Animals
The study was performed using male Wistar rats (Ifa Credo, Barcelona, Spain) weighing between 250 and 300 g. All animals were fasted for 12 hrs before surgery, anesthetized with urethane 10% (10 mL/kg, intraperitoneally), and placed in a supine position keeping body temperature at 36 -37°C. All procedures were approved by the Institutional Review Board of our institution and followed European guidelines for the handling and care of laboratory animals, which were in accord with National Institutes of Health guidelines for ethical animal research.
Intestinal Transplantation
The animals underwent a heterotopic transplant following the technique described by Monchik and Russell (20) . Donor rats underwent a xiphopubic laparotomy, and the entire small intestine was isolated from the Treitz ligament to the vicinity of the ileocecal valve. The portal vascular pedicle was prepared by transecting all pancreatic, gastric, and splenic vessels. After we isolated a segment of the aorta with the superior mesenteric artery of the neighboring structures, the artery was perfused in situ with 5 mL of University of Wisconsin (UW) preservation solution at 4°C. Following the technique of double flushing (21) , the intestinal lumen was irrigated with the same solution (10 mL) before the graft was extracted.
To induce cold ischemia, the removed jejunum was preserved in 25 mL of UW at 4°C for 6 hrs.
The recipient animals underwent a xiphopubic laparotomy in the same conditions. After isolation of the infrarenal aorta and vena cava, the arterial flow was reestablished by end-to-side anastomosis of a segment of the aorta containing the superior mesenteric artery of the donor to the infrarenal aorta of the recipient. The venous flow was reestablished by end-to-side anastomosis of the portal vein of the donor to the infrarenal vena cava of the recipient. The distal end of the ileum was anastomosed end-to-side to the ileum of the recipient, whereas the proximal end of the graft was occluded. The total time of warm reperfusion was 3 hrs.
Experimental Groups
Animals were randomly assigned to the studied groups (n ϭ 5 rats each) as follows (Table 1) :
Control group: group 1 (C). The specimen was obtained and immediately processed without cold preservation (sham).
Control ischemic group: group 2 (CI). The specimen was preserved for 6 hrs in 25 mL of UW solution and then processed.
Transplanted group: group 8 (Trp). The specimen was preserved for 6 hrs in 25 mL of UW solution and then transplanted with 3 hrs of reperfusion.
Groups treated with FDP: groups 3 and 9 (CIϩFDP, TrpϩFDP). FDP (5 mM) was dissolved in the total volume used per animal (40 mL ϭ 5 mL vascular flushing ϩ 10 mL intestinal lumen flushing ϩ 25 mL cold storage) at pH 7.4.
Groups treated with theophylline: groups 4 and 10 (CIϩT, TrpϩT): Theophylline (2.8 mM) was also dissolved in the total volume used per animal (40 mL).
Groups treated with FDP and theophylline: groups 5 and 11 (CIϩFDPϩT, TrpϩFDPϩT). Both substances were added as described previously to assess if both substances had a synergistic effect.
Groups treated with FDP and erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA): groups 6 and 12 (CIϩFDPϩEHNA, TrpϩFDPϩEHNA). EHNA, an inhibitor of adenosine deaminase (22) , was added to the preservation solution in the group treated with FDP, to evaluate whether enhancement of endogenous adenosine increased or counteracted the FDP effect on apoptosis. EHNA (500 g per animal) was dissolved only in 10 mL of the total volume of UW solution, which was used to flush the intestinal lumen. FDP was administered as described previously.
Groups treated with Z-Val-Ala-Asp(OMe)-Fluoromethylketone (zVAD-fmk) (23): groups 7 and 13 (CIϩzVAD-fmk, TrpϩzVAD-fmk). Treatment with the pancaspase inhibitor zVAD-fmk, which interacts with the active site of the cleaved caspases, was used as a negative control. zVAD-fmk (250 g per animal) was dissolved previously in dimethyl sulfoxide and then in 1 mL of saline solution. It was administered by direct puncture into the inferior cava 1 hr before the cold ischemia. This dose of zVAD-fmk proved to be effective in previous studies (23) .
For groups 2-7, at the end of cold ischemia, the preserved jejunum was divided into three parts: One segment was freeze-clamped to evaluate nucleotides and nucleosides; another segment was processed for immunohistochemical analyses; and, in the third part, mucosa was obtained to determine caspase-3 activity and to perform Western blot analysis of cleaved caspase-3.
The other experimental groups, groups 8 -13, were subjected to intestinal transplantation for the evaluation of apoptosis effect on BT, neutrophil infiltration, and histology.
Biochemical Analyses
Nucleotide and Nucleoside Determination. Intestinal samples were processed by highpressure liquid chromatography as previously described (24) .
Caspase-3 Activity. Caspase-3 activity was determined by measuring proteolytic cleavage of the specific substrate N-acetyl-Asp-Glu-Val-Asp-7-amino-4-methylcoumarin (DEVD-AMC; Biomol, Plymouth Meeting, PA). Intestinal mucosa was homogenized and sonicated in assay buffer (50 mM 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid [HEPES], 10% sucrose, 0.1% CHAPS, 5 mM oxidized glutathione, 5 mM dithiothreitol; pH ϭ 7.4). We used 25 g of protein of each sample and 12 M DEVD-AMC to perform the assay. The AMC released was quantified for 1 hr at 37°C by fluorospectrophotometry using 380 nm excitation and measurement of 450 nm emission. Caspase-3 activity was calculated from data obtained during the first 30 mins by extrapolation to an AMC standard curve. Under these conditions, the assay remained linear for Ն30 mins. Western Blot Analysis. Protein was quantified in the same homogenates used for caspase-3 activity measurement (50 mM HEPES, 10% sucrose, 0.1% CHAPS, 5 mM GSSG, 5 mM DTT; pH ϭ 7.4) with 1 mM phenylmethylsulfonyl fluoride added as protease inhibitor. Then 80 g of protein per lane was electrophoresed in 16% sodium dodecyl sulfate gel. Proteins were transferred to nitrocellulose membranes, which were subsequently blocked with 5% nonfat dry milk in 0.06% Tween-TBS for 1 hr. Membranes were incubated with primary antibody (anti caspase-3 at 1:800 dilution; Serotec, Oxford, UK) overnight at 4°C. Membranes were washed five times with 0.06% Tween-TBS and then incubated for 1 hr with a horseradish peroxidase conjugated antirabbit immunoglobulin G antibody (dilution 1:5000) at room temperature. Membranes were washed five times with 0.06% Tween-TBS, followed by electrogenerated chemiluminescence detection.
Myeloperoxidase Assay. Myeloperoxidase was measured in intestinal tissue spectrophotometrically by employing 3,3',5,5'-tetramethylbenzidine as substrate, as described previously (25) .
Histologic Analyses
Immunohistochemistry. A segment of jejunum was fixed in formalin 4%. Tissue was embedded in paraffin and cut into 3-m sections. Slides were deparaffinized and incubated for 20 mins with 3% hydrogen peroxide to block endogenous peroxidase activity. Antigen retrieval was performed by boiling the slides for 20 mins with 10% EDTA 1 mM (pH ϭ 8). Sections were incubated for 1 hr with fetal bovine serum, and after washing, they were incubated with rabbit anti-active caspase-3 polyclonal antibody (dilution 1:10.000, Becton Dickinson, PharMingen, San Diego, CA) overnight at 4°C. After washing, the slides were incubated with a secondary antibody biotinylated anti-rabbit (dilution 1:500; Vector Laboratories, Burlingame, CA) for 1 hr. Antigen-antibody complexes were detected incubating the slides with horseradish peroxidase avidin (Vector Laboratories) for 1 hr, developed by the addition of diaminobenzidine chromogen substrate (Vector Laboratories).
TUNEL Staining. Cell death was detected in situ by enzymatic labeling of DNA strand breaks using the In Situ Cell Death Detection Kit, AP (Roche Molecular Biochemicals, Mannheim, Germany) according to the manufacturer's instructions.
Histopathologic Analysis
Intestinal tissue was embedded in 4% formalin-fixed paraffin and cut into 3-m sections and stained with hematoxylin-eosin. Three blinded independent observers evaluated the histologic sections by using Park's classification (26) , which was scored as fol-lows: 0, normal mucosa; 1, subepithelial space; 2, extended subepithelial space; 3, epithelial lifting along villus side; 4, denuded villi; 5, loss of villus tissue; 6, crypt layer infarction; 7, transmucosal infarction; and 8, transmural infarction.
Microbiological Analyses
Bacterial Translocation. BT from the graft to mesenteric nodes was assessed quantitatively. Tissue samples were removed using a sterile technique and weighed. Samples were homogenized in 2 mL of saline solution, and 0.01 mL of each homogenate was placed in McConkey and blood agar plates. After incubation at 37°C, bacterial counts were performed at 48 and 72 hrs by an independent observer in a blinded fashion. Results were expressed as logs of colony formation units per gram of tissue.
Statistical Analyses. Data are expressed as mean Ϯ SEM. Means of different groups were compared using one-way analysis of variance. Student-Newman-Keuls' test was used to evaluate significant differences between groups. The Mann-Whitney rank sum test was used in the histopathologic analysis. Significant differences were assumed when p Ͻ .05. Figure 1A shows the tissue levels of adenosine after 6 hrs of cold ischemic preservation. Intestinal adenosine levels decreased after 6 hrs of ischemia compared with the control group and increased significantly in the FDP and FDP plus theophylline groups (p Ͻ .05). Addition of the adenosine deaminase inhibitor (EHNA) to the FDP group increased adenosine levels. Treatment with zVAD-fmk or theophylline alone did not show any significant change compared with the cold ischemia group.
RESULTS
ATP and Adenosine Levels at the End of Cold Ischemia
As expected, ATP tissue levels decreased after 6 hrs of cold ischemia compared with the control group. Nevertheless, none of the studied treatments had any effect on ATP levels when compared with those of the cold ischemia group (Fig. 1B) . Figure 2 shows the results of caspase-3-like activity after cold ischemic preservation. At 6 hrs of preservation, caspase-3-like activity was significantly enhanced compared with the control group (p Ͻ .05). Addition of FDP or theophylline alone to the preservation solution significantly decreased caspase-3 activity compared with the CI group (p Ͻ .05). When theophylline was administered together with FDP, the decrease was more pronounced and indeed significantly lower than with FDP alone (p Ͻ .01). By contrast, addition of the adenosine deaminase inhibitor EHNA to the FDP group returned caspase-3 activity to the level of the CI group. As expected, administration of the caspase inhibitor zVADfmk significantly decreased caspase-3 activity after 6 hrs of cold ischemia, even though at this dose the inhibitor did not eliminate caspase activity completely (p Ͻ .05).
Apoptotic Assessment at the End of Cold Ischemia
To confirm the results on the activation of caspase-3, Western blot analyses of the cleaved active form (17 kDa) were performed. There was a close correlation between the two variables, as shown in Figure 3 . The intensity of cleaved caspase-3 increased after 6 hrs of ischemia compared with control. The low activity found in the FDP plus theophylline treated group (CIϩFDPϩT) was concomitant with a decrease in cleaved caspase-3 expression, whereas addition of the adenosine deaminase inhibitor EHNA to FDP group (CIϩFDPϩEHNA group) increased cleaved caspase-3 expression. FDP treatment (CIϩFDP), theophylline treatment (CIϩT), or caspase-3 inhibitor treatment (CIϩzVAD-fmk) decreased the intensity of the expression of cleaved caspase-3 compared with CI, but the effect was less pronounced than that observed in CIϩFDPϩT group.
The results of immunohistochemical analyses and terminal deoxynucleotidyl transferase-mediated biotin-dUTP nickend labeling (TUNEL) staining agreed with the other apoptotic variables (Fig.  4) . The control group showed positive staining of the active fragment of caspase-3, predominantly at the tips of villus and in some isolated cells in the lamina propia, which increased after 6 hrs of preservation (Fig. 4A ). Comparing the amount of immunoreactivity in the various groups with the CI group, we found that the group treated with FDP showed a decrease (Fig. 4B ), which was more evident when theophylline was added to the same group (Fig. 4C ). Addition of EHNA to FDP (CIϩFDPϩEHNA) again increased the immunoreactivity of the slides (Fig. 4D) . In our study of TUNEL staining, we focused on the presence of positive staining on the crypts. The number of TUNEL-positive cells was calculated in 50 small intestinal crypts per slide ( Table 2 ). The tendency was the same as that observed for the other variables ( Fig. 4, E-H) . Table 3 and Figure 5 show the degree of histologic injury according to Park's classification after 6 hrs of cold ischemia and 3 hrs of reperfusion. The architecture of the villi was normal in control rats, corresponding to a degree of injury 0. The highest degree of histologic injury was found in the transplant-only group (Trp) and in the TrpϩFDPϩEHNA group, which presented a massive lifting of the villi and exposure of the lamina propia, corresponding to a degree of injury be- tween 3 and 4 (Fig. 5A) . When FDP, theophylline, or zVAD-fmk was added to the transplant group (TrpϩFDP, TrpϩT, and TrpϩzVAD-fmk groups), the degree of histologic injury decreased significantly, showing better preservation of the villi architecture comparing to Trp group (Fig. 5B, p Ͻ .01) . Similar to the control group, the TrpϩFDPϩT group did not show histologic injury (degree 0 -1), and the epithelium remained almost normal (Fig. 5C ). Figure 6 shows BT in the mesenteric lymph nodes of the recipient. No BT was found in the control group. The transplant-only group showed high levels of BT in the lymph nodes. Addition of FDP (TrpϩFDP group) showed a trend to reduce BT, which was significant when theophylline was added alone (TrpϩT) or together with FDP (TrpϩFDPϩT, p Ͻ .01). Endogenous adenosine accumulation (TrpϩFDPϩEHNA group) showed the highest BT levels. Caspase-3 inhibitor treatment (TrpϩzVAD-fmk) decreased significantly BT compared with the transplant-only group (p Ͻ .05). Figure 7 shows neutrophil infiltration measured as myeloperoxidase activity in the transplanted intestines. Results revealed an increase after transplantation, which was significantly decreased by FDP or theophylline addition (p Ͻ .05) and even more by addition of both substances together (TrpϩFDPϩT group, p Ͻ .01). In addition, caspase inhibitor administration also showed a significant decrease in neutrophil infiltration comparing to the Trp-only group (p Ͻ .05).
Histologic Evaluation After Transplantation
Bacterial Translocation After Intestinal Transplantation
Neutrophil Infiltration After Intestinal Transplantation
DISCUSSION
FDP provides cytoprotection for tissues and improves ischemic conditions through different pathways, which include prevention of ATP depletion, inhibition of neutrophil free radical production, prevention of platelet activation, stimulation of nitric oxide synthase, chelation of extracellular calcium, and stabilization of the plasma membrane (10 -12) . All these pathways affected by FDP may be involved in apoptosis modulation, as free radical production that modulates apoptosis in some models (27) and as nitric oxide, which has been reported to be both apoptotic (24) and antiapoptotic (28) . We hypothesized that FDP added to the preservation solution could affect early apoptosis development, and we found here that grafts preserved with FDP-UW solution showed a decreased activation of apoptosis after 6 hrs of preservation. Therefore, our study extends FDP's known protective role to include apoptotic-mediated events during intestinal preservation.
FDP improves ischemic conditions in several organs during preservation (10 -12) . The primary action of FDP has been postulated as metabolic. During oxygen deprivation, FDP would improve ATP supply vs. demand (29) . Given that the most frequently reported protective effect of FDP is its ability to increase glycolytic energy production, we explored whether this effect was due to the improvement of ATP stores. The results of previous studies on this issue are controversial. Some have shown increased ATP stores (29, 30) , but others indicated no change after treatment with FDP (31) . In our case, we found no significant differences in ATP levels when FDP was added to the preservation solution.
Other studies indicate that pretreatment with FDP in I/R is able to modify the nucleoside pool, leading to an increase in adenosine levels during ischemia (15) . Like FDP, the purine nucleoside adenosine has previously been shown to reduce I/R-associated injury in a range of organs by a mechanism that involves the improvement of energy use during ischemia (32, 33) . The effect of adenosine on apoptosis regulation has been studied in vitro and in vivo in different models with different results. In the present research, we hypothesized that the mechanism by which FDP exerts its antiapoptotic action could be influenced by increased adenosine levels. Our results indicate that FDP treatment preserved adenosine tissue levels after 6 hrs of preservation, concomitant with a decrease in apoptosis. Nevertheless, endogenous strong accumulation of adenosine on the FDP-UW solution by EHNA promoted apoptosis. Therefore, our results suggest that the mechanism by which FDP reduces apoptosis is not mediated by enhancement of adenosine levels.
The mechanism by which FDP modulates apoptosis remains unclear. A possible explanation could be its interaction with cell membranes to stimulate lipolysis (34) . Among the products of membrane lipolysis, diacylglycerol and inositol triphosphate influence proliferation and apoptosis (35, 36) . By the activation of phospholipase C, diacylglycerol and inositol triphosphate are involved in the phosphorylation and subsequent activation of Bcl-2 (37) , which is known to protect against apoptosis (38) . It has also been reported that ketohexoses like FDP protect hepatocytes from necrosis and apoptosis by a mechanism that is unrelated to iron chelation or glycolytic metabolism, suggesting that early cell death signals may be inhibited by fructose and other ketohexoses (14) .
Since BT is an undesired consequence of intestinal transplantation, effective methods of preventing BT as well as the knowledge of mediators and mechanisms involved in BT prevention are vital to achieve a successful intestinal transplantation. This study indicates that addition of theophylline alone or together with FDP during preservation maintains BT near to control levels after intestinal transplantation. Several mechanism of action have been described to explain some of the physiologic and pharmacologic properties of theophylline that might be related to the effects observed in this work. At the cellular level, it is a weak and nonselective inhibitor of phosphodiesterases (39), leading to an increase in cyclic adenosine monophosphate, which has been described as effective in minimizing the development of apoptosis in cold stored liver grafts (40) or improving postischemic recovery in cold preserved intestines (41). By contrast, apoptosis promotion by theophylline has also been reported; this role has been related to phosphodiesterase inhibition, adenosine receptors antagonism (39) , and, recently, phosphoinositide 3-kinase inhibition (42) . This effect, described mainly in inflammatory cells, would contribute to the anti-inflammatory and immunomodulatory properties reported for this drug (43) , which agrees with our results regarding neutrophil infiltration decrease when theophylline was administered. Moreover, theophylline, by limiting inflammatory reaction during intestinal I/R, may contribute to BT prevention, since epithelial secretion, which has been suggested to play a role in limiting BT, may be altered as a consequence of inflammation (44) . Despite the fact that the exact mechanism is currently unknown, theophylline seems to have a direct effect on BT independent of apoptosis. Nevertheless, apoptosis behavior during preservation is also related to BT and graft histologic injury after transplantation (as shown by the effect of caspase inhibition on these results), indicating the relevance of apoptosis events during preservation for the success of intestinal graft. In addition, neutrophil infiltration was clearly de-creased in the groups where apoptosis was found to be minor. This finding suggests a relationship between apoptosis and inflammation, previously described in other models (45) .
CONCLUSION
The present findings show that FDP decreases apoptosis development during intestinal preservation by a mechanism independent of adenosine and ATP enhancement. Even more, addition of theophylline alone or in conjunction with FDP to the preservation solution is able to maintain apoptosis in intestine at a low level for 6 hrs of hypothermic preservation, prevents BT after transplantation, and may thus favor graft survival upon transplantation. 
